Home | Business News | Browse by Publication | B | Business Wire

MEDIA ADVISORY: Oncology Notables Gather to Discuss Tumor-Selective Medicines; OXiGene's Chief Scientific Officer Discusses Mechanism of Action and Clinical Results of Combretastatin A4P at Royal Pharmaceutical Society Meeting.

Publication: Business Wire
Publication Date: 12-OCT-05 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
WALTHAM, Mass. -- OXiGENE, Inc. (NASDAQ: OXGN)(XSSE: OXGN):

-- Presentation Included the Clinical Significance of the Recently-Announced and Newly-Identified Mechanism of Action of CA4P and the Relevance of this Mechanism in Clinical Trials Evaluating CA4P Administered in Combination with Radiotherapy

-- Early Clinical Evidence of Patient Survival Benefit is Supported by Biological Evidence of Enhanced Blood Flow Shutdown

OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a leading developer of biopharmaceutical compounds to treat cancer and certain ophthalmologic diseases, announced that its Chief Scientific Officer, Dr. David Chaplin, presented today at the Tumour-Selective Medicines meeting held at the Royal Pharmaceutical Society of Great Britain, in cooperation with the Academy of Pharmaceutical Sciences. Dr. Chaplin joined prominent scientists in the field of oncology in discussing the development of highly targeted anti-tumor medicines.

Dr. Chaplin focused his presentation on extensive preclinical and clinical data garnered from academic institutions worldwide that have demonstrated that CA4P, when administered following a...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
Patent Information for Leading Generic Drugs is Available Through Piri..., October 12, 2005
Independent Proxy Voting Advisors Recommend Shareholders of The Salomo..., October 12, 2005
Maricopa Medical Center Selects CDEX's ValiMed Technology for End Prod..., October 12, 2005
StubHub and Travelocity Team Up to Serve the Traveling Football Fan; F..., October 12, 2005
Mutual Fund Firms Provide Little Advisor Education, Says Corporate Ins..., October 12, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.